Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Leukotriene antagonists prepared by Leo

July 18, 1997

Nisshin Flour Milling describes new antiasthma drugs

July 17, 1997

Arris and Bayer modify collaboration

July 17, 1997

Neurokinin antagonists developed at Zeneca

July 16, 1997

Dual H1/NK1 antagonists from Hoechst Marion Roussel

July 15, 1997

Sanwa Kagaku discloses novel selectin inhibitors for inflammatory disorders

July 10, 1997

Kotobuki describes new compound with expectorant and antiinflammatory effects

July 8, 1997

Novartis discovers compounds with anti-PDE IV and other actions

July 8, 1997

Update on Alliance/Hoechst Marion Roussel agreement for LiquiVent

July 7, 1997

Orally active H3 receptor agonist prodrug with antiinflammatory/antinicoceptive properties

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...